ArticleCureus2025
First Trimester Echogenic Lung Lesions: A Diagnostic Challenge and Review of Differential Diagnoses.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Foetal echogenic lungs are characterised by the appearance of small bright spots within the foetal lungs observed via antenatal ultrasound, which may indicate underlying developmental abnormalities. The presence of echogenic lungs is a rare sonographic finding identified during the first trimester of pregnancy. In this report, we present the case of a healthy 25-year-old primigravida who was found to have multiple foetal abnormalities in her routine first-trimester scan, following which she was scanned by the foetal medicine team, who confirmed the finding of foetal echogenic lungs along with cystic hygroma and hydrops foetalis. Turner's syndrome was confirmed with successive invasive tests, and the pregnancy was terminated at 14 weeks. Our findings not only contribute to the limited data on this rare sonographic occurrence but also highlight the importance of vigilant foetal monitoring in cases of echogenic lungs, allowing for timely intervention and management strategies. This case strongly supports the need for further research into the implications of echogenic lung findings and their association with chromosomal abnormalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.